About Us
Stay Informed.
Sign-up for the SynBioBeta Weekly Digest and stay on top of all the industry news.
Thank you!
We'd love to ask a few more questions to better customize your experience.
Oops! Something went wrong while submitting the form.
Thank You!
We'd love to get to know you just a bit more.
Take a few minutes to personalize your content.
What is the size of your company?
Synbio Stack?
Synbio Stack?
Thank you!
You are now subscribed.
Oops! Something went wrong while submitting the form.
Weekly Digest

Neubase Therapeutics

Fiona Mischel
Published -
October 11, 2021

Almost every human disease is driven by genetics. So what if we could cure every genetic disease, from Alzheimer's to cancer?

These may sound like lofty aspirations. But the team at Neubase Therapeutics has developed a method for temporarily modifying disease-causing genes without permanently altering the genome. The backbone of Neubase's technology is also highly adaptable. If successful, the company could only need to make small tweaks to develop a brand new therapy, avoiding years of difficult and expensive clinical trials.

Tune in to hear more about Neubase's cutting-edge approach and much more!

Want to ask your question live in one of our shows? Be sure to follow @SynBioBeta! #builtwithbiospaces

Keep in touch!

Fiona Mischel (Host)

Neubase Therapeutics:

Subscribe to the Built with Biology Digest for Spaces shows, news across the bioengineering world, upcoming events, and more!

Learn more about Race Against the Clock here!

Episode credits: Hosted by Fiona Mischel, produced by Nikita Michelsen, and recorded, edited, and engineered by Bryce Joseph-Nelson

Recorded: 9/22/21